TWO SIGMA INVESTMENTS, LP - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 60 filers reported holding OVID THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$9,713
-92.2%
12,628
-68.9%
0.00%
Q1 2024$124,040
-89.0%
40,669
-85.9%
0.00%
-100.0%
Q2 2021$1,129,000
+41.3%
288,780
-16.5%
0.00%
+50.0%
Q4 2020$799,000
-56.5%
345,706
+7.9%
0.00%
-71.4%
Q3 2020$1,838,000
+1897.8%
320,265
+932.7%
0.01%
+600.0%
Q1 2020$92,000
-86.9%
31,012
-81.6%
0.00%
-50.0%
Q4 2019$700,000
+3584.2%
168,602
+1528.7%
0.00%
Q2 2019$19,000
-74.7%
10,352
-75.6%
0.00%
Q1 2019$75,000
-34.2%
42,360
-10.4%
0.00%
Q4 2018$114,00047,2630.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,540,671$2,835,0001.27%
Madison Avenue Partners, LP 1,394,022$2,565,0000.55%
BVF INC/IL 6,851,051$12,606,0000.52%
CHI Advisors LLC 864,822$1,591,0000.43%
Rubric Capital Management LP 4,516,300$8,310,0000.42%
EcoR1 Capital, LLC 6,117,400$11,256,0000.33%
Artal Group S.A. 2,500,000$4,600,0000.20%
DCF Advisers, LLC 162,701$299,0000.19%
Oasis Management Co Ltd. 270,000$497,0000.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 908,500$1,672,0000.04%
View complete list of OVID THERAPEUTICS INC shareholders